Cite
[Cancer, onco-haematological treatment and cardiovascular toxicity]
MLA
E, Mena Sebastiá, et al. “[Cancer, Onco-Haematological Treatment and Cardiovascular Toxicity].” Hipertension y Riesgo Vascular, vol. 38, no. 2, Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a0fe717dba75938735748e55cbd80efc&authtype=sso&custid=ns315887.
APA
E, M. S., L, T. S., R, V. V., F, L. G., & R, F.-P. (2020). [Cancer, onco-haematological treatment and cardiovascular toxicity]. Hipertension y Riesgo Vascular, 38(2).
Chicago
E, Mena Sebastiá, Tirapu Sola L, Villanueva Vázquez R, Losa Gaspà F, and Freixa-Pamias R. 2020. “[Cancer, Onco-Haematological Treatment and Cardiovascular Toxicity].” Hipertension y Riesgo Vascular 38 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........a0fe717dba75938735748e55cbd80efc&authtype=sso&custid=ns315887.